InvestorsHub Logo
Followers 3
Posts 160
Boards Moderated 0
Alias Born 11/16/2020

Re: None

Wednesday, 02/24/2021 12:38:58 PM

Wednesday, February 24, 2021 12:38:58 PM

Post# of 36590
https://www.google.ca/amp/s/www.proactiveinvestors.com/companies/amp/news/941929

Cydy phase 3 study for leronlimab was only 397 patients for completion. Sharing results after regulatory talks next two weeks. I really wonder why rvv wouldn’t be able to share data and why it couldn’t be unblinded at say 400 pts or apply for EUA if say cydy whole trial was 397 and their being unblinded and sounds like applying for EUA